All Events

Filter by

Event Date

Filter by Event Date

Done
Lecture Series Logo: NHLBI 70 Years of Discovery
Natcher Auditorium A & Auditorium B
This year, 2018, marks the 70th Anniversary of the establishment of the National Heart, Lung, and Blood Institute. 

NHLBI began as the National Heart Institute on June 16, 1948, when President Harry S. Truman signed the National Heart Act. The Framingham Heart Study began the same year. In 1969, the Institute expanded its mission (and name) to cover research on lung diseases, and in 1976, the Institute grew further to include blood disorders.

To commemorate the Institute's 70th anniversary and showcase important investments in scientific research, NHLBI will feature lectures throughout the year from prominent thought leaders representing areas of high scientific priority in heart, lung, blood, and sleep disorders.

The talks will be available to the public in-person and online via videocast.
December 9 - 12, 2017
Atlanta, GA
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health will participate in the 59th American Society of Hematology (ASH) Annual Meeting. NHLBI-supported research will be presented at more than 40 sessions. See the schedule below for a snapshot of the NHLBI’s sessions at 59th ASH Annual Meeting.
November 11 - 15, 2017
Anaheim, CA
The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) will participate in the 2017 American Heart Association (AHA) Scientific Sessions from November 11 to 15, 2017 in Anaheim, California. NHLBI research and NHLBI-funded research will be presented at more than 50 sessions. See the schedule below for a snapshot of the NHLBI’s sessions at AHA 2017. The schedule is subject to change.
November 7 - 8, 2017
Rockledge Two, 9th Floor, Suite 9100/9104, 6701 Rockledge Drive, Bethesda, MD, 20892
Despite progress made in delivering evidence-based interventions for heart, lung, blood, and/or sleep disorders or diseases (HLBS conditions), these conditions remain major causes of death and disability. The National Heart, Lung, and Blood Institute (NHLBI) convened management and clinicians from Community Health Centers (CHC); clinical pharmacists; HLBS specialists; community-based participatory researchers; leaders from schools of pharmacy; and Federal stakeholders, from National Institute for Nursing Research (NINR), Health Resources and Services Administration (HRSA), Centers for Disease and Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), National Cancer Institute (NCI). Community Health Centers, including Federally Qualified Health Centers (FQHC), are a healthcare safety net for low income and uninsured populations and provide outpatient care for one-out-of-every-twelve Americans. A better understanding of the barriers and facilitators for CHCs to deliver evidence-based prevention and control for HLBS disorders is needed. Recommendations from this workshop will provide NHLBI options to consider to advance late-stage translation research (T4TR) within the CHC setting.
SUNY Global Center
Midtown Manhattan
The 2017 NIH Innovation Conference will provide investment-ready small businesses funded by NIH with pitch coaching and networking with experienced life science business professionals to prepare them for the Life Sciences Summit the following day.
October 26 - 27, 2017
Jamaica Pegasus Hotel, Jamaica West Indies
SCiF is a two-day, intensive, educational update on sickle cell disease. The 11th annual SCiF conference will be co-hosted by the National Heart, Lung, and Blood Institute and The University of West Indies.
October 25 - 26, 2017
Lipsett Auditorium (Building 10)
This conference will bring together leading experts in the field to discuss cutting-edge research in five key areas of systems biology: single-cell epigenomics, imaging-based systems biology, quantitative and integrative proteomics, systems biology of metabolism and large-scale data integration.
September 27 - 28, 2017
NIH Main Campus
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodeling and inflammation, vascular remodeling and inflammation, and tissue engineering/genome editing/new technologies.
September 21 - 22, 2017
Bethesda, MD
The National Heart, Lung, and Blood Institute (NHLBI) convened a Working Group meeting on September 21-22, 2017 in Bethesda, MD to assess the latest research findings in heart failure with preserved ejection fraction (HFpEF); identify research gaps and barriers that are specific to HFpEF; discuss emerging research methodologies on how best to address the identified knowledge gaps and barriers; and develop recommendations for research directions in HFpEF for the next 5-10 years. The Working Group consisted of leading experts in heart failure, HFpEF, and related fields.